Testing 1
Determine 1&2 HIV Test Kits
RAPID ANTIBODY/Finger Prick 10 to 15 Minute Results An antibody test is also known as a serology test looks for the presence of antibodies, which are specific proteins made in response to infections. It is effective at detecting the recent past SARS-CoV2 infection. This test can detect the body's IgM Antibody response in as little as 7 days (IgG in 14 days) from infection with CDC validated 100% specificity and 100% sensitivity. The highest accuracy serological test on the market FDA EUA Approved Manufactured by one of the leaders in lateral flow technology Results in 10-15 minutes FINGER PRICK NO LAB RESULTS REQUIRED
Specification Strength/ Size Packing Size Packed In HIV 1 & 2 Card Test Triline 50 Tests 50 Box Pack
* KOREA Brand : 1) GenBody 2) ASAN PHARAM 3) SD BIOSENSOR 4) BIOCREDIT 5) Wells Bio * Test Type : IgG/IgM Antigen, antibody test * Accuracy rate : 92%~95% * Read result time : 5~10 mins * Package : 25 kit + 1 Reagent / 1 box * Price : FOB Korea 8.5 ~ 10.5 USD / 1 kit * MOQ : 10,000 KIT * Payment Terms : T/T 50% advance and Balance SGS inspection * Product Certificate : KFDA, CE, FDA
Covid-19 Self Test Kit We are the authorized first vendor of ADTech! KFDA CE approved, FDA Pending Price : Negotiable Pre-Clinical Test Report Accuracy - In total samples 93.3% (14/15) - In positive samples 91.7% (11/12) 1. Pre-Clinical Test summary 1) Pre-clinical test is fulfilled by Domestic large clinical laboratory with ADTech COVID-19 IgM/IgG RAPID KIT 2) Tests are made by total 15 samples with 12 positive and 3 negative samples 3) Clinical Laboratory tested the sample with Immunofluorescence Analysis 2. Pre-clinical test result 1) Samples were tested by ADTech COVID-19 IgM/IgG RAPID KIT 2) Test result by ADTechs RAPID KIT - 4 negatives and 11 positives results in 15 samples 3) Comparison between Immunofluorescence analysis and ADTechs RAPID KIT - 14 test results are same(including negative and positive results) - 1 samples test result are different(Positive Negative by ADTech
For in vitro qualitative detect of Covid-19 antigen in nasal(NS) swab specimens directly from individuals who are suspected of COVID-19 by their healthcare provider within the first 5 days of the onset of the symptoms. This test is only provided for use by clinical laboratories or to healthcare workers for point-of-care testing, and not for at home testing. 1.Easy to collect samples simple operation without professional equipment. 2.The test results are available in 15 minutes, and the test results are clearly visible. 3.Convenient transportation and low price, higher accuracy. 4.Suitable for large-scale rapid screening. Shelf life: 24 Months Test Result time: 10 Mins Packing: 25 Pieces per Box
Product Details: Number of Reactions(Preps)/Kit :30T Brand : SD Biosensor ICMR Approved : Yes Result Time (Rapid Kits) : 10 min CAT No : RK019-30 STANDARD Q HIV 1/2 Ab 3-Line performs qualitative analysis by detecting antibodies specific to HIV-1 (including Group O) and HIV-2 in serum, plasma and whole blood using immunochromatography. With a simple test method, HIV infection status can be discriminated, and with its high sensitivity and specificity, the screening test result can be obtained within 10 minutes. Easy to use, Easy to read and interpret Discrimination between HIV-1 and HIV-2 antibodies Room temperature storage Performance Sensitivity : 100% (74/74)/ Specificity : 100% (232/232)
Experiments: Study of Reflex Klystron Frequency, Guide Wavelength Measurement SWR, Reflection Coefficient Measurement Impedance Measurement Instruments: SKPS 1 VSWR Meter 1 Components: Cooling Fan1 Detector Mount 1 Fixed Short 1 D.R.F. Meter1 Isolator 1 Klystron Mount 1 Matched Termination1 Movable Short1 S S Tuner1 Slotted Section 1 Tunable Probe 1 Variable Attenuator 20 dB 1 Wave Guide Stand 4 Accessories: BNC to BNC Cable2 Mains Cord 2 Op. Manual 1
COVID-19 Rapid Test Kit IgG + IgM (Colloidal Gold) comes in packs of 40 tests and contains: GCMS manufactures COVID-19 antigen test kit, the GENEDIA W COVID-19 Ag which is listed on the EU common list, also with GMP and ISO certifications. GENEDIA W COVID-19 Ag is unaffected based on the in-silicon analysis of the mutations in the nucleocapsid (N gene) of Omicron viruses. Letter of statement is available upon your request. To get over COVID-19 pandemic, especially the recent Omicron breakout, currently we are doing big promotions for three kinds of COVID-19 Ag kit. All are in stock and available right away. 1. Nasopharyngeal 2. Nasal 3. Saliva Price and Minumum Quantity Price FOB in USD: negotiable 0.8 to 1.8Minimum Order Qty: None Pieces Production Capacity: 3,000,000/monthPackaging: 20 Tests/kit, 30 Kits/box, 12 Boxes/pallet Sample: Available. Sample Cost Born By Supplier Product Model And Origin Brand: GENEDIAModel: 643G-S (Saliva) Seller Code: Genedia w covid 19 agHS Code: 3002.15 Standards: Ce Competitive Advantages Allow wider testing with fast test time (10 minutes) All necessary materials provided / no equipment needed Sensitivity: 93.33%, specificity: 100% Free sample. no moq. price is negotiable. customized packing. Other Details 20 tests / kit 24 months from the date of manufacture 2 ~ 30c(35.6 ~ 86f) available for room temperature deliver In stock. fast delivery. 1 x Instructions for Use Manual 40 x Test Cassettes 1 x Buffer 40 x Dropper
1 test *500BOX/CTN home self test kit MOQ 2000
Product Details: Brand J.Mithra Test Kit Type: Dengue Test Kit (Rapid) Sensitivity & Specificity High Shelf Life: 30 months at 2-30 DegreeC Pack Size: 10, 30 & 50 Tests Cat. No IR028010 Intended Use : Dengue Day 1 Test is a rapid solid phase immuno-chromatographic test for the qualitative detection of Dengue NS1 Antigen and differential detection of IgM and IgG antibodies to Dengue virus in Human serum/plasma. This test is for in vitro diagnostic use only and is intended as an aid in the earlier diagnosis of Dengue infection & presumptive diagnosis between primary and secondary Dengue infection. Salient Features: First line testing kit for detecting dengue infection from day 1 using NS1 Antigen & differential detection of IgM & IgG Antibodies. Diagnosis of both Primary & Secondary Infection. Detection of all the 4 Dengue serotypes (DEN-1, DEN-2, DEN-3 and DEN-4). Highly Sensitive & Highly Specific Long shelf life: 30 months at 2-30 C. Convenient pack sizes: 10 Tests, 30 Tests & 50 Tests. Principle:Dengue Day 1 test kit consists of two devices: one device for detection of Dengue NS1 antigen and second device for the differential detection of Dengue IgM/IgG antibodies in Human serum/plasma. Dengue NS1 Antigen device contains two lines; (Control line) & T (Dengue NS1 Antigen test line). Test line is coated with anti-dengue NS1 Ag. When a sample is added to the device, Dengue NS1 antigen if present in the sample will bind to the anti-dengue NS1 gold colloidal conjugate making antigen antibodies complex. This complex migrates along the membrane to the test region and forms the visible pink line at as antibody-antigen-antibody gold colloid forms. Dengue IgM/IgG test device contains three lines; C (Control line), M (IgM test line) & G (IgG test line).IgM test line is coated with anti-human IgM and IgG test line is coated with anti-human IgG.When a sample is added to the device, IgG and IgM antibodies in the sample react with anti-human IgM or IgG antibodies coated on the membrane respectively. Colloidal gold complexes containing dengue 1-4 antigens is captured by the bound anti-dengue IgM or IgG on respective test bands located in the test window causing a pale to dark red band to form at the IgG or IgM region of the test device window. The intensity of the test bands in the respective device will vary depending upon the amount of antigen /antibody present in the sample. The appearance of any pink/ red colour in a specific test region should be considered as positive for that particular antigen and/or antibody type (IgG or IgM). A red procedural control line should always develop in the test device window to indicate that the test has been performed properly Dengue NS1 Ag : Sensitivity 96% and Specificity 98%. Dengue IgM/IgG Antibody test : Sensitivity 95% and Specificity 97%.
Angiten-COVID-19 Virus Test Kit (Colloidal Gold) Quantity of box: 25 persons/box Brand: Easysweet NMPA (National Medical Products Administration): Approved CE: with CE mark BfArM: listed Test Method: Antigen Test Result Time: 10-15 mins Sample Type: Nasal Swab Sensitivity: 96.70% Specificity: 100% Accuracy: 98.94% Shelf Life: 24 months Storage Temperature: 2-30 Degree Celsius Country of Origin: Made in China Additional Information: Production Capacity: 1 million Delivery Time: 10-15 days Packaging Details: 25 tests in a pack, 40packs/ carton Angiten-COVID-19 Virus Test Kit is an in vitro diagnostic rapid test for the qualitative detection of SARS-CoV-2 antigen (Ag) in human nasopharyngeal swab specimens from individuals who meet COVID-19clinical and / or epidemiological criteria. It can be used by professional only. Price and Minumum Quantity Price FOB in USD: NegotiableMinimum Order Qty: 10000 Production Capacity: 1000000Packaging: 25 Persons/box Sample: Available. Sample Cost Born By Buyer Product Model And Origin Brand: Easysweet HS Code: 3822009020 Standards: Ce Competitive Advantages Best price with shortest delivery time Best price with shortest delivery time Best price with shortest delivery time Best price with shortest delivery time Other Details Angiten-covid-19 virus test kit (colloidal gold) Angiten-covid-19 virus test kit (colloidal gold) Angiten-covid-19 virus test kit (colloidal gold) Angiten-covid-19 virus test kit (colloidal gold)
Access Bio Care Start Covid-19 Rapid Antigen Test Kit Product Details: Number of Reactions(Preps) per Kit : 1 Brand : Access Bio Test Method : Antigen Test Result Time (Rapid Kits) : 10 min Sample Type ; Nasal Swab Packaging Size : 20 Test Kits/Box Packaging Type : Box The CareStart COVID-19 Antigen test is a lateral flow immunochromatographic assay intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal or anterior nasal swab specimens directly collected from individuals who are either suspected of COVID-19 by their healthcare provider within first five days of symptom onset, or from individuals without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 48 hours between